Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
ANNX.OQ - Annexon Inc
Annexon Inc to Host KOL Event
Mar 18, 2026 / 06:00PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Alrighty folks, well, listen, good afternoon everyone, and thank you for joining us today. I'm Doug Love, President and CEO of an Exxon Biosciences, and we're excited, delighted that you've joined us this afternoon for our investor day focused on Va Pruitt for the treatment of geographic atrophy or GA. Here we'll discuss its robust scientific and clinical underpinnings that support the vision sparing data that we've seen in our phase 2 study and really gives us a great deal of encouragement for our phase 3 program.
We'll be making forward-looking statements of course and we direct you to our legal disclosures here and on file.
So over the course of today's program, you'll hear from members of the An Exxon management team as well as
Trustpilot
